Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases

被引:16
作者
Aertgeerts, K
DeRanter, CJ
Booth, NA
Declerck, PJ
机构
[1] UNIV ABERDEEN,DEPT MOL & CELL BIOL,ABERDEEN AB25 2ZD,SCOTLAND
[2] CATHOLIC UNIV LEUVEN,FAC PHARMACEUT SCI,LAB PHARMACEUT BIOL & PHYTOPHARMACOL,B-3000 LOUVAIN,BELGIUM
关键词
D O I
10.1006/jsbi.1997.3860
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Considerable progress in understanding the mechanism of inhibition of proteinases by serpins has been obtained from different biochemical studies. These studies reveal that stable serpin/proteinase complex formation involves insertion of the reactive-site loop of the serpin and occurs at the acyI-enzyme stage, Even though no three-dimensional structure of a serpin/proteinase complex is resolved, structural information is available on some of the individual compounds. Molecular modeling techniques combined with recently acquired biochemical/biophysical data were used to provide insight into the stable complex formation between plasminogen activator inhibitor-1 (PAI-1) and the target proteinases: tissue-type plasminogen activator, urokinase-type plasminogen activator, and thrombin., This study reveals that PAI-1 initially interacts with its target proteinase when its reactive-site loop is solvent exposed and thereby accessible for the proteinase. Stable complex formation, however, involves the insertion of the reactive-site loop up to P7 and results in a tight binding geometry between PAI-1 and its target proteinase. The influence of different biologically relevant molecules on PAI-1/proteinase complex formation and the differences in inhibition rate constants observed for the different proteinases can be explained from these models. (C) 1997 Academic Press.
引用
收藏
页码:236 / 242
页数:7
相关论文
共 50 条
[1]   MECHANISMS CONTRIBUTING TO THE CONFORMATIONAL AND FUNCTIONAL FLEXIBILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
AERTGEERTS, K ;
DEBONDT, HL ;
DERANTER, CJ ;
DECLERCK, PJ .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (10) :891-897
[2]   Biochemical and biophysical studies of reactive center cleaved plasminogen activator inhibitor type 1 - The distance between P3 and P1' determined by donor-donor fluorescence energy transfer [J].
Aleshkov, SB ;
Fa, M ;
Karolin, J ;
Strandberg, L ;
Johansson, LBA ;
Wilczynska, M ;
Ny, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (35) :21231-21238
[3]   CRYSTAL-STRUCTURE OF CLEAVED HUMAN ALPHA-1-ANTICHYMOTRYPSIN AT 2.7-A RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS [J].
BAUMANN, U ;
HUBER, R ;
BODE, W ;
GROSSE, D ;
LESJAK, M ;
LAURELL, CB .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 218 (03) :595-606
[4]  
BJORK I, 1993, BIOCHEMISTRY-US, V32, P6501
[5]   THE REFINED 1.9 A CRYSTAL-STRUCTURE OF HUMAN ALPHA-THROMBIN - INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT [J].
BODE, W ;
MAYR, I ;
BAUMANN, U ;
HUBER, R ;
STONE, SR ;
HOFSTEENGE, J .
EMBO JOURNAL, 1989, 8 (11) :3467-3475
[6]   NATURAL PROTEIN PROTEINASE-INHIBITORS AND THEIR INTERACTION WITH PROTEINASES [J].
BODE, W ;
HUBER, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (02) :433-451
[7]   BIOLOGICAL IMPLICATIONS OF A 3-ANGSTROM STRUCTURE OF DIMERIC ANTITHROMBIN [J].
CARRELL, RW ;
STEIN, PE ;
WARDELL, MR ;
FERMI, G .
STRUCTURE, 1994, 2 (04) :257-270
[8]   STRUCTURE AND ENERGETICS OF LIGAND-BINDING TO PROTEINS - ESCHERICHIA-COLI DIHYDROFOLATE REDUCTASE TRIMETHOPRIM, A DRUG-RECEPTOR SYSTEM [J].
DAUBEROSGUTHORPE, P ;
ROBERTS, VA ;
OSGUTHORPE, DJ ;
WOLFF, J ;
GENEST, M ;
HAGLER, AT .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1988, 4 (01) :31-47
[9]  
DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454
[10]  
EHRLICH HJ, 1992, J BIOL CHEM, V267, P11606